Mack Anthony P. 13D/13G Filings for Virpax Pharmaceuticals, Inc. (VRPX)

Mack Anthony P. 13D and 13G filings for Virpax Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-14
4:05 pm
Purchase
2022-12-31 13G Virpax Pharmaceuticals, Inc.
VRPX
Mack Anthony P. 12,322
26.100%
451increase
(+3.80%)
Filing
2022-02-14
4:34 pm
Purchase
2021-12-31 13G Virpax Pharmaceuticals, Inc.
VRPX
Mack Anthony P. 11,872
25.200%
11,872increase
(New Position)
Filing